Latest Breaking News On - Antony blanc - Page 10 : comparemela.com
Corona-News: Pathologe: Großteil stirbt an, nicht mit Covid
t-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from t-online.de Daily Mail and Mail on Sunday newspapers.
Corona-News: Länder erwarten erste Impfstoff-Lieferung von Astrazeneca
t-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from t-online.de Daily Mail and Mail on Sunday newspapers.
Britain on Friday said it had agreed on a deal with German biotech firm CureVac to work to develop vaccines against coronavirus variants, placing an initial order for 50 million doses in case they are needed. Prime Minister Boris Johnson has cited the possibility of new variants of the coronavirus as one of the biggest risks to the vaccine rollout and hopes that the economy can start to be reopened from lockdown in the spring. The government said both the Pfizer/BioNTech and Oxford/AstraZeneca vaccines being currently rolled out appear to work well against variants currently dominant in Britain. But we must be prepared for all eventualities and bolster onshore UK manufacturing capacity to develop vaccines to combat new variants of the disease, taking advantage of our world-leading genomics expertise, health minister Matt Hancock said in a statement.
Britain to work with Germany s CureVac on vaccines against coronavirus variants Toggle share menu
Advertisement
Britain to work with Germany s CureVac on vaccines against coronavirus variants Britain on Friday said it had agreed on a deal with German biotech firm CureVac to work to develop vaccines against coronavirus variants, placing an initial order for 50 million doses in case they are needed.
FILE PHOTO: CureVac s experimental COVID-19 vaccine is given to a volunteer in clinical trials
05 Feb 2021 09:22PM Share this content
Bookmark
LONDON: Britain on Friday (Feb 5) said it had agreed on a deal with German biotech firm CureVac to work to develop vaccines against coronavirus variants, placing an initial order for 50 million doses in case they are needed.
CureVac, U.K. Government Agree to Develop Future Covid Shots Bloomberg 2/5/2021 Tim Loh
(Bloomberg) CureVac NV will collaborate with the U.K. to develop vaccine candidates against coronavirus variants, with the government securing 50 million doses of any successful shot.
The German biotech will work with the U.K.’s vaccine task force in assessing mutated strains that emerge, and clinical studies in the U.K. may be expedited for faster regulatory clearance, according to a statement Friday. The move extends the country’s investment in Covid-19 prevention as Britain races ahead of the European Union in vaccinations.
CureVac is forging partnerships in a bid to accelerate the development and roll out of its experimental messenger-RNA Covid vaccines, which are similar to the ones already being administered to tens of millions of people from Pfizer Inc. and BioNTech SE, along with Moderna Inc.
vimarsana © 2020. All Rights Reserved.